BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37132252)

  • 1. Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.
    Zhu F; Li F; Xie X; Wu Y; Wang W
    Cancer Med; 2023 Jun; 12(12):13290-13299. PubMed ID: 37132252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.
    Zhao Y; Shi W; Dong F; Wang X; Lu C; Liu C
    Front Endocrinol (Lausanne); 2022; 13():1098204. PubMed ID: 36733797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
    Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
    J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.
    Shuai Y; Yue K; Duan Y; Zhou M; Fang Y; Liu J; Liu D; Jing C; Wu Y; Wang X
    Front Endocrinol (Lausanne); 2021; 12():620147. PubMed ID: 34211434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of nomograms for predicting the risk of central lymph node metastasis of solitary papillary thyroid carcinoma of the isthmus.
    Li Y; Gao X; Guo T; Liu J
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):14853-14868. PubMed ID: 37598343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.
    Luo Z; Hei H; Qin J; Zheng C; Gong W
    Endocrine; 2022 Dec; 78(3):484-490. PubMed ID: 36018538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total tumor diameter: the neglected value in papillary thyroid microcarcinoma.
    Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
    J Endocrinol Invest; 2020 May; 43(5):601-613. PubMed ID: 31749082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
    Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
    Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms to predict ipsilateral and contralateral central lymph node metastasis in clinically lymph node-negative patients with solitary isthmic classic papillary thyroid carcinoma.
    Feng JW; Qu Z; Ye J; Hong LZ; Liu SY; Wang F; Jiang Y; Hu J
    Surgery; 2021 Dec; 170(6):1670-1679. PubMed ID: 34275617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
    Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
    World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
    Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node yield in the initial central neck dissection (CND) associated with the risk of recurrence in papillary thyroid cancer: A reoperative CND cohort study.
    Yu ST; Ge JN; Sun BH; Wei ZG; Xiao ZZ; Zhang ZC; Chen WS; Li TT; Lei ST
    Oral Oncol; 2021 Dec; 123():105567. PubMed ID: 34710736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.
    Weitzman RE; Justicz NS; Kamani D; Kyriazidis N; Chen MH; Randolph GW
    Laryngoscope; 2022 Sep; 132(9):1883-1887. PubMed ID: 35229306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
    Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
    Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unilateral Tnm T1 And T2 Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: Total Thyroidectomy or Lobectomy?
    Wang Z; Xiang J; Gui Z; Qin Y; Sun W; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Lv C; Zhang P; Zhang H
    Endocr Pract; 2020 Oct; 26(10):1085-1092. PubMed ID: 33471710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.